[HTML][HTML] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug discovery today, 2015 - Elsevier
Highlights•We provide a SWOT analysis of peptide therapeutics and discuss commercial
aspects.•We comment on emerging peptide technologies and cell-penetrating peptides.• …

[PDF][PDF] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - academia.edu
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - infona.pl
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

[PDF][PDF] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - csmres.co.uk
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

[引用][C] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - cir.nii.ac.jp
Peptide therapeutics: current status and future directions | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

[PDF][PDF] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - rawpeg.com
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

Peptide therapeutics: current status and future directions.

K Fosgerau, T Hoffmann - Drug Discovery Today, 2014 - europepmc.org
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

[PDF][PDF] Peptide therapeutics: Current status and future directions

KFT Hoffmann - Diabetes, 2014 - cyberleninka.org
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

[PDF][PDF] Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug Discovery Today, 2015 - rawpeg.com
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …

Peptide therapeutics: current status and future directions

K Fosgerau, T Hoffmann - Drug discovery today, 2015 - pubmed.ncbi.nlm.nih.gov
Peptides are recognized for being highly selective and efficacious and, at the same time,
relatively safe and well tolerated. Consequently, there is an increased interest in peptides in …